Welcome to the Journal of Clinical and Diagnostic Research, a leading open-access journal published by the PREMCHAND SHANTIDEVI RESEARCH FOUNDATION since 2007. This journal serves as a crucial platform for researchers and professionals in the fields of biochemistry, genetics, and molecular biology, with a particular focus on clinical biochemistry. The journal is recognized for its commitment to disseminating high-quality research, fostering academic dialogue, and enabling practitioners to stay at the forefront of advancements in diagnostic methods. With an ISSN of 2249-782X, the journal enhances accessibility to critical research findings and discussions, ensuring that the scientific community and interested students can engage with valuable insights. Although coverage has been discontinued in Scopus since 2018, its rankings within the clinical biochemistry domain reflect a dedicated scholarly impact that continues to influence research trajectories. We invite you to explore the wealth of knowledge presented in the Journal of Clinical and Diagnostic Research and contribute to the evolving discourse in clinical science.

Annals of Clinical and Analytical Medicine, published by BAYRAKOL MEDICAL PUBLISHER, is a premier open-access journal dedicated to advancing the field of clinical and analytical medicine. With the evolving landscape of healthcare, this journal serves as a crucial platform for the publication of high-quality research that encompasses a wide range of topics in medical science, offering insights into innovative clinical practices and analytical methodologies. The journal, identifiable by its E-ISSN 2667-663X, promotes the dissemination of knowledge by providing unrestricted access to its articles, thus ensuring that researchers, healthcare professionals, and students can stay abreast of the latest findings and developments. As it continues to gain recognition, Annals of Clinical and Analytical Medicine aims to foster an inclusive dialogue within the global medical community, encouraging collaboration and promoting high-impact research that addresses pressing healthcare challenges.

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

Welcome to the Alexandria Journal of Medicine, a premier open-access publication dedicated to advancing medical knowledge and practice since its inception in 2016. Published by the respected Taylor & Francis Ltd, this journal provides a platform for the dissemination of innovative research in all areas of medicine. With an increasing focus on accessibility, the journal ensures that its valuable content is available to a global audience, fostering collaboration and dialogue among healthcare professionals, researchers, and students alike. The Alexandria Journal of Medicine encourages rigorous peer-reviewed articles that present novel findings, systematic reviews, and insights into clinical practices, making it an essential resource for those at the forefront of medical research. Leveraging a commitment to quality and relevance, this journal aims to impact the ever-evolving landscape of healthcare and contribute to better health outcomes worldwide.

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

REVUE DE MEDECINE INTERNE, published by Elsevier France - Editions Scientifiques Medicales Elsevier, is a prominent French journal dedicated to the fields of internal medicine and gastroenterology. With a publication history dating back to 1980 and extending through 2024, this journal offers a platform for the dissemination of significant research findings, case studies, and reviews pertinent to these disciplines. Despite its current status in Quartile 3 of both gastroenterology and internal medicine categories, REVUE DE MEDECINE INTERNE aims to elevate its academic contribution through rigorous peer-reviewed articles that inform clinical practice and advance medical knowledge. Although not currently available as an open-access journal, it remains a vital resource for medical professionals, researchers, and students seeking to enhance their understanding of internal medicine and its various subspecialties. This journal is essential for those wishing to stay abreast of the latest developments in patient care, diagnostic methods, and treatment protocols in France and beyond.

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.